Simple protein test could improve prediction of survival rates for patients with head and neck cancer

January 24, 2014

(Medical Xpress)—Scientists from The University of Manchester – part of the Manchester Cancer Research Centre - used a simple protein test that could prove more useful in predicting survival chances for patients with head-and-neck cancer compared to existing methods.

The team, funded by Cancer Research UK, believe the test could allow doctors to choose more appropriate and tailored treatments.

Oral cancers, including the tongue and tonsils, are usually associated with tobacco and alcohol intake. However, increasing numbers of cases are instead linked to human papillomaviruses (HPV) - which occur in younger people and have a different biology and a better prognosis.

One approach for detecting HPV-associated oral cancer relies on finding HPV DNA in the tumour sample but these DNA-based tests may not accurately classify the tumour. Another approach is to use a marker of HPV rather than testing for HPV DNA directly. The protein usually disappears in tumours that are not caused by HPV infection and has been proposed as a surrogate marker of HPV.

The researchers looked at differences in clinical characteristics, treatment and survival between p16-positive and p16-negative oral cancers in a large group of 217 patients.

Professor Catharine West, from The University of Manchester and Manchester Cancer Research Centre who led the research, said: "We know that in most cases, p16 is linked to differences in survival. We wanted to see how it compared to other measures such as the stage of disease – which tells us the size and spread of the cancer. Anything that allows us to predict outcome could help doctors plan more personalised treatments for individual patients."

The study, published in the journal Clinical Oncology, shows that the presence of p16 in a tumour was strongly linked to increased survival. They found that tumour stage was linked to survival in p16-negative tumours, but not in p16-positive tumours.

Professor West said: "Despite presenting with a more advanced stage of , patients whose tumours tested positive for p16 had greater survival when compared with p16-negative patients.

"Applying this test in the clinic could help guide treatment decisions and potentially allow doctors to choose more appropriate and tailored treatments."

"Many studies have now shown p16 status is strongly linked to . Now we have shown the test works better than routine staging for some cancers, we would recommend this test be offered as standard," added Professor West.

Jessica Kirby, Cancer Research UK's senior health information manager, said: "This study clearly shows that testing for HPV status using p16 levels can be valuable as one of a number of ways doctors determine their patients' prognosis. HPV-associated head and neck cancers are becoming much more common over time, and there's a wealth of evidence that patients with HPV-positive tumours tend to have better outcomes than HPV-negative ."

Explore further: Number of cancer stem cells might not predict outcome in HPV-related oral cancers

More information: "The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.", Oguejiofor KK, Hall JS, Mani N, Douglas C, Slevin NJ, Homer J, Hall G, West CM. Clin Oncol (R Coll Radiol). 2013 Nov;25(11):630-8. DOI: 10.1016/j.clon.2013.07.003. Epub 2013 Jul 31.

Related Stories

Number of cancer stem cells might not predict outcome in HPV-related oral cancers

January 22, 2014
(Medical Xpress)—New research from The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) suggests that it may be the quality ...

HPV improves survival for African-Americans with throat cancer

March 28, 2013
Even though the human papillomavirus (HPV) is a risk factor for certain head and neck cancers, its presence could make all the difference in terms of survival, especially for African Americans with throat cancer, according ...

HPV improves survival for African-Americans with throat cancer

July 19, 2012
Even though the human papillomavirus (HPV) is a risk factor for certain head and neck cancers, its presence could make all the difference in terms of survival, especially for African Americans with throat cancer, say Henry ...

HPV leaves its mark in oropharyngeal squamous cell carcinoma

May 1, 2013
Oropharyngeal squamous cell carcinoma (OPSCC) is a form of cancer that affects the cells lining the middle part of the throat, including the soft palate, the base of the tongue, the tonsils, and the pharynx.

HPV test for oral cancers may improve patient outcomes, facilitate targeted therapy

November 5, 2012
(Medical Xpress)—A new test designed to classify tonsil and throat cancers into one of two groups should help deliver the right treatment to the right patients, according to research being presented at the NCRI Cancer Conference ...

Rating HPV biomarkers in head, neck cancers: Combinations work better than viral DNA in tumors alone

September 18, 2012
Not all head and neck cancers are created equal. Those started by infection with the human papillomavirus are less often fatal than those with other causes, such as smoking. Detection of a reliable fingerprint for HPV could ...

Recommended for you

Retaining one normal BRCA gene in breast, ovarian cancers influences patient survival

August 22, 2017
Determining which cancer patients are likely to be resistant to initial treatment is a major research effort of oncologists and laboratory scientists. Now, ascertaining who might fall into that category may become a little ...

Study provides insight into link between two rare tumor syndromes

August 22, 2017
UCLA researchers have discovered that timing is everything when it comes to preventing a specific gene mutation in mice from developing rare and fast-growing cancerous tumors, which also affects young children. This mutation ...

Study identifies miR122 target sites in liver cancer and links a gene to patient survival

August 22, 2017
A new study of a molecule that regulates liver-cell metabolism and suppresses liver-cancer development shows that the molecule interacts with thousands of genes in liver cells, and that when levels of the molecule go down, ...

Zebrafish larvae could be used as 'avatars' to optimize personalized treatment of cancer

August 21, 2017
Portuguese scientists have for the first time shown that the larvae of a tiny fish could one day become the preferred model for predicting, in advance, the response of human malignant tumors to the various therapeutic drugs ...

Scientists discover vitamin C regulates stem cell function, curbs leukemia development

August 21, 2017
Not much is known about stem cell metabolism, but a new study from the Children's Medical Center Research Institute at UT Southwestern (CRI) has found that stem cells take up unusually high levels of vitamin C, which then ...

Searching for the 'signature' causes of BRCAness in breast cancer

August 21, 2017
Breast cancer cells with defects in the DNA damage repair-genes BRCA1 and BRCA2 have a mutational signature (a pattern of base swaps—e.g., Ts for Gs, Cs for As—throughout a genome) known in cancer genomics as "Signature ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.